ROCK IMMUNE LLC
Denver, CO · Biotech · Private
Bispecific immunotoxin therapeutic (CCR4-IL2 fusion protein) for cutaneous T-cell lymphoma, produced via diphtheria toxin-resistant yeast expression system
- Grants
- $2.5M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma | $400,000 | |
| Federal grant | Department of Health and Human Services · Phase II · CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma | $875,832 | |
| Federal grant | Department of Health and Human Services · Phase II · CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma | $248,336 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3264 | RESILIO THERAPEUTICS, LLC | — | — |
| 3265 | GCFREE, INC. | — | — |
| 3266 | NIGHTSTAR BIOTECHNOLOGIES, INC | — | — |
| 3267 | ROCK IMMUNE LLC | — | — |
| 3268 | PROBIOME THERAPEUTICS, INC. | — | — |
| 3269 | Outer Biosciences Inc | — | $23M |
| 3270 | Prelenia | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.